Avid Bioservices 

€8.25
15
+€0+0% 今天

统计数据

当日最高
8.25
当日最低
8.25
52周最高
-
52周最低
-
成交量
0
平均成交量
-
市值
373.42M
市盈率
54.42
股息收益率
-
股息
-

即将到来

收益

3Dec预期
Q1 2023
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Q2 2024
下一个
-1.94
-1.28
-0.62
0.04
预期每股收益
-0.0975
实际每股收益
N/A

人们还关注

此列表基于关注TEHP.F的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.
Show more...
首席执行官
Mr. Nicholas Stewart Green B.Sc., MBA
员工
371
国家
US
ISIN
US05368M1062
WKN
000A2JBKV

上市公司